Atlas FDA

HEARTMATE(R) VE LVAS

FDA premarket approval P920014/S007 · decided 1998-09-29

Approval details

PMA number
P920014
Supplement
S007
Supplement type
Panel Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
HEARTMATE(R) VE LVAS
Generic name
Ventricular (assist) bypass
Applicant
Thoratec Corp
Date received
1997-07-02
Decision date
1998-09-29
Days to decision
454 days
Decision code
APPR
Product code
DSQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Pleasanton, CA
Statement
approval for the HeartMate(R) VE LVAS. This device is indicated for use as a bridge to transplantation in cardiac transplant candidates at risk of imminent death from nonreversible left ventricular failure. The HeartMate(R) VE LVAS is indicated for use both inside and outside the hospital.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CENTRIMAG PRIMARY CONSOLE (2ND GENERATION); MAG MONITOR (K131179)Thoratec Corp2013-07-18